Dubai Dubai Dubai is at the heart of our IMETA region. Explore career development opportunities in the UAE or our 170 locations around the globe.
Brand of the Year Frontline pet parasiticides Brand of the Year Frontline pet parasiticides FRONTLINE® Wins Brand of the Year Award for the Third Time in a row
Boehringer Ingelheim attends WVPAC 2019 Boehringer Ingelheim attends WVPAC 2019 Boehringer Ingelheim attends and showcases its leading vaccines and services at 21st World Veterinary Poultry Association Congress
BI_X_Shanghai BI_X_Shanghai Boehringer Ingelheim opens a second branch of its digital lab in Shanghai
A tool to aid in the prevention of African swine fever A tool to aid in the prevention of African swine fever ASF COMBAT is an online management and biosecurity assessment tool aimed at reducing the African swine fever introduction risk level.
Blue internal teat sealant now in dairy mastitis portfolio Blue internal teat sealant now in dairy mastitis portfolio Boehringer Ingelheim adds blue internal teat sealant to its dairy mastitis portfolio
TwistPak Mixing platform for swine vaccines TwistPak Mixing platform for swine vaccines TwistPak® allows for fresh mixing of Ingelvac CircoFLEX® and Ingelvac MycoFLEX® on farm in less than 5 seconds
Technologies Technologies We are expanding our global network of technology partners Learn more about partnering with us.
More Health Overview More Health Overview Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Boehringer expands production site in Greece Boehringer expands production site in Greece Boehringer expands production site in Greece for new medicine
Award: Boehringer Ingelheim is Global Top Employer 2022 Award: Boehringer Ingelheim is Global Top Employer 2022 Global Top Employer 2022
Lifelong learning at our Virtual Campus Lifelong learning at our Virtual Campus The Virtual Campus of our Boehringer Ingelheim University supports our employees in their personalized lifelong learning.
Reduction of Salmonella in swine after vaccination Reduction of Salmonella in swine after vaccination Authorities acknowledge reduction of Salmonella after vaccination with Enterisol® Ileitis
Classical Swine Fever live vaccine approved in China Classical Swine Fever live vaccine approved in China Boehringer Ingelheim’s China-developed Classical Swine Fever live vaccine approved
Outlook for Partnering in Animal Health 2024 Outlook for Partnering in Animal Health 2024 Megan Grether, Head of Business Development & Licensing for Animal Health, shares her perspectives on the year ahead for partnering in Animal Health.
Our Biotech Story | Bioxcellence | Boehringer Ingelheim Our Biotech Story | Bioxcellence | Boehringer Ingelheim Discover our pioneering history & leadership in biotechnology, driving innovation in biopharmaceutical manufacturing & breakthrough therapies.
Agreement-to-acquire-NBE-Therapeutics Agreement-to-acquire-NBE-Therapeutics Boehringer Ingelheim to acquire NBE-Therapeutics to significantly enhance cancer pipeline portfolio with antibody-drug conjugates.
FreVAX smartphone application piglet vaccination FreVAX smartphone application piglet vaccination New FreVAX™ smartphone application brings piglet vaccination to another level
Research Beyond Borders overview Research Beyond Borders overview Learn more about how our Research Beyond Borders team is uncovering new ideas and new science.
bix_facilitates_global_partnerships bix_facilitates_global_partnerships BI X focuses on partnerships to speed up the development of digital healthcare solutions
Boehringer Ingelheim acquires Global Stem cell Technology Boehringer Ingelheim acquires Global Stem cell Technology Boehringer Ingelheim acquires Global Stem cell Technology, Belgian veterinary biotech company, to strengthen its stem cell capabilities in Animal Health